Viz Aneurysm, the first fully-automated AI algorithm to receive FDA-clearance, detects suspected cerebral aneurysms, which can potentially rupture if not actively monitored. Mobile, HIPAA-compliant communication tools ensure that the aneurysm workflow across the entire health system is standardized, so more patients get neurovascular follow-up.